Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.

NCT02294396 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

649

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder (OAB)

Interventions

DRUG: Mirabegron tablet
DRUG: Solifenacin tablet
DRUG: Propiverine tablet
DRUG: Imidafenacin tablet
DRUG: Tolterodine capsule

Sponsor

Astellas Pharma Inc